zurück

22. NZW Europe

Peliminary Program as to 15th January 2014

Thursday, 23th January 2014 ESOP-Delegates-Meeting and Public Session
Time Title Speaker  
08:30-14:00 ESOP-Board meeting
 
14:00-15:00 Break
 
15:00-19:00 ESOP-Delegate meeting part I
 


Friday, 24th January 2014 ESOP-Delegates-Meeting and Public Session
Time Title Speaker  
08:00-12:30 ESOP-Delegate meeting part II
 
12:30-13:30 Break
 
14:00-18:00 ESOP meetings
 
13:30-15:00 ESOP “Contamination project” meeting
 
15.00-15.25 Break
 
  Chair: Dr. Vesna Pavlica
Zagreb, Croatia
15.25-15.45 New Place of Olanzapine in the Treatment of CINV Dr. Irena Netíková
Prague, Czech Republic
15.45-16.05 Medication Safety in Oncology Carole Chambers
Calgary, Canada
16.05-16.25 Patient Counseling – ESOP Project Mina Kovacevic
Ljubljana, Slovenia
16.25-16.45 Rational Prescribing - The Role of the Pharmacist and the Hospital Drug Formulary

Stavroula Theophanous-Kitiri


Strovolos, Cyprus
17:00-18:00 ESOP “Clean working group” meeting
 


Saturday, 25th January 2014 Lectures *
Time Title Speaker  
08.15 Welcome ISOPP
Welcome ADKA

Carole Chambers
Dr. Torsten Hoppe-Tichy

Calgary, Canada
Heidelberg, Germany

08.30-09.00 Predictive Molecular Pathology: A Prerequisite of Personalized Medicine
Prof. Dr. Manfred Dietel Berlin, Germany
09.00-09.30 Quo Vadis Regenerative Medicine? - of Stem Cells, Regeneration, Aging and Cancer

Prof. Dr. Mariusz Z. Ratajczak

Louisville, USA

09.30-10.00

Legal Framework for Bidding Procedures by Statutory Health Insurances in Oncology Pharmacy

Dr. Alexander Csaki

Düsseldorf, Germany

10.00-10.30

Take 29 Steps to develop an Integral Pharmaceutical Care Plan for Oncology Patients

Dr. Mirjam Crul
Kathleen Simons

Amsterdam & Tilburg
The Netherlands

13.00-14.00

Lunch Break

 

 

 

Chair:

Michael Höckel, Kassel, Germany

 

14.00-14.25

Therapeutic Drug Monitoring of Imatinib in Patients with CML

Katarzyna Sobańska

Poznań, Poland

14.25-14.50

Selected Adverse Effects and Interactions of  low-molecular Kinase Inhibitors

Jürgen Barth

Gießen, Germany

14.50-15.15

Therapeutic Drug Monitoring in Cancer, are we missing a Trick?

Dr. Christophe Bardin

Paris, France

15.15-15.40

Miscibility of Infusions

Oliver Feth
Dr. Rainer Trittler

Stade, Germany
Freiburg, Germany

15.40-16.10

Break

 

 

 

Chair

Dr. Reinhard Hanpft

Hamburg, Germany

16.10-16.35

Drug Shortages: how we have been coping. 
A 3-year detailed Overview from a Dutch University Medical Center.

Prof. Dr. Arno G. Vulto

Rotterdam, The Netherlands

16.35-17.00

Chemotherapy Drug Shortages in Europe: A Call to Action

Prof. Dr. Günther Wiedemann

Ravensburg, Germany

17.00-17.25

Who is afraid of Biosimilars?

Prof. Dr. Huub Schellekens
Prof. Dr. Arno G. Vulto

Utrecht, The Netherlands
Rotterdam, The Netherlands

17.25-17.50

Biosimilars und Good Pharmaceutical Practice in Inpatient Settings

Prof. Dr. Irene Krämer

Mainz, Germany



*simultaneously translated German-English


| Mehr